What is the clinical evidence from this study?

Study design: Review. Population: Atrial Fibrillation and Metabolic Syndrome. Intervention: Cardiometabolic risk factors (Obesity, Hypertension, Diabetes, Dyslipidemia) vs. Absence of cardiometabolic risk factors.

June 30, 2013Reviews in Cardiovascular MedicineOpen Access

Cardiometabolic Risk Factors and Atrial Fibrillation

View Full Paper

Ask AI

Bookmark

Key result

Cardiometabolic risk factors, including obesity, hypertension, and diabetes, are significantly associated with an increased risk of developing and recurring atrial fibrillation.

Design

Review

Authors

AMArthur R. Menezes CLCarl J. Lavie JDJames J. DiNicolantonio

Discussion

Member takes

Overview

Supports MetS-AF association in existing data; leaves open causality and whether targeting components alters AF incidence.

PICO

Population

A review of the literature examining the association between cardiometabolic risk factors (obesity, hypertension, diabetes, dyslipidemia) and the development or recurrence of atrial fibrillation.

Exposure / Comparator

Cardiometabolic risk factors (Obesity, Hypertension, Diabetes, Dyslipidemia) vs Absence of cardiometabolic risk factors

This review summarizes the relationship between metabolic syndrome components and the development or pathophysiology of atrial fibrillation.

Limitations

The role of ACE inhibitors and ARBs in preventing AF remains controversial with conflicting study results.
The association between type 2 diabetes and AF, as well as statin use and AF prevention, remains controversial and subject to debate.
Data suggesting obesity predicts progression from paroxysmal to permanent AF are very limited.

Cite This Study

Menezes et al. (2013) conducted a review in Atrial Fibrillation and Metabolic Syndrome. Cardiometabolic risk factors (Obesity, Hypertension, Diabetes, Dyslipidemia) vs. Absence of cardiometabolic risk factors was evaluated. Cardiometabolic risk factors, including obesity, hypertension, and diabetes, are significantly associated with an increased risk of developing and recurring atrial fibrillation.

synapsesocial.com/papers/6a6184c22004386bc7d0aecd https://doi.org/10.3909/ricm0693

View Full Paper

Ask AI

Bookmark

June 30, 2013Reviews in Cardiovascular MedicineOpen Access

Cardiometabolic Risk Factors and Atrial Fibrillation

View Full Paper

Ask AI

Bookmark

Key result

Cardiometabolic risk factors, including obesity, hypertension, and diabetes, are significantly associated with an increased risk of developing and recurring atrial fibrillation.

Design

Review

Authors

AMArthur R. Menezes CLCarl J. Lavie JDJames J. DiNicolantonio

Discussion

Member takes

Overview

Supports MetS-AF association in existing data; leaves open causality and whether targeting components alters AF incidence.

PICO

Population

A review of the literature examining the association between cardiometabolic risk factors (obesity, hypertension, diabetes, dyslipidemia) and the development or recurrence of atrial fibrillation.

Exposure / Comparator

Cardiometabolic risk factors (Obesity, Hypertension, Diabetes, Dyslipidemia) vs Absence of cardiometabolic risk factors

This review summarizes the relationship between metabolic syndrome components and the development or pathophysiology of atrial fibrillation.

Limitations

The role of ACE inhibitors and ARBs in preventing AF remains controversial with conflicting study results.
The association between type 2 diabetes and AF, as well as statin use and AF prevention, remains controversial and subject to debate.
Data suggesting obesity predicts progression from paroxysmal to permanent AF are very limited.

Cite This Study

synapsesocial.com/papers/6a6184c22004386bc7d0aecd https://doi.org/10.3909/ricm0693

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark